State Street’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Hold |
265,263
| – | – | ﹤0.01% | 3814 |
|
|
2025
Q1 | $243K | Hold |
265,263
| – | – | ﹤0.01% | 3777 |
|
|
2024
Q4 | $252K | Buy |
265,263
+60,100
| +29% | +$57.1K | ﹤0.01% | 3789 |
|
|
2024
Q3 | $261K | Hold |
205,163
| – | – | ﹤0.01% | 3763 |
|
|
2024
Q2 | $267K | Buy |
205,163
+11,800
| +6% | +$15.3K | ﹤0.01% | 3735 |
|
|
2024
Q1 | $296K | Hold |
193,363
| – | – | ﹤0.01% | 3779 |
|
|
2023
Q4 | $226K | Hold |
193,363
| – | – | ﹤0.01% | 3873 |
|
|
2023
Q3 | $168K | Hold |
193,363
| – | – | ﹤0.01% | 3984 |
|
|
2023
Q2 | $217K | Hold |
193,363
| – | – | ﹤0.01% | 3984 |
|
|
2023
Q1 | $201K | Hold |
193,363
| – | – | ﹤0.01% | 4081 |
|
|
2022
Q4 | $217K | Hold |
193,363
| – | – | ﹤0.01% | 4068 |
|
|
2022
Q3 | $219K | Hold |
193,363
| – | – | ﹤0.01% | 4097 |
|
|
2022
Q2 | $284K | Hold |
193,363
| – | – | ﹤0.01% | 4058 |
|
|
2022
Q1 | $443K | Buy |
193,363
+9,475
| +5% | +$21.7K | ﹤0.01% | 4102 |
|
|
2021
Q4 | $506K | Hold |
183,888
| – | – | ﹤0.01% | 4019 |
|
|
2021
Q3 | $1.1M | Buy |
183,888
+18,300
| +11% | +$110K | ﹤0.01% | 3759 |
|
|
2021
Q2 | $806K | Buy |
165,588
+125,848
| +317% | +$613K | ﹤0.01% | 3704 |
|
|
2021
Q1 | $98K | Sell |
39,740
-13,960
| -26% | -$34.4K | ﹤0.01% | 3904 |
|
|
2020
Q4 | $147K | Hold |
53,700
| – | – | ﹤0.01% | 3783 |
|
|
2020
Q3 | $83K | Hold |
53,700
| – | – | ﹤0.01% | 3728 |
|
|
2020
Q2 | $101K | Hold |
53,700
| – | – | ﹤0.01% | 3658 |
|
|
2020
Q1 | $91K | Hold |
53,700
| – | – | ﹤0.01% | 3627 |
|
|
2019
Q4 | $156K | Hold |
53,700
| – | – | ﹤0.01% | 3655 |
|
|
2019
Q3 | $34K | Hold |
53,700
| – | – | ﹤0.01% | 3742 |
|
|
2019
Q2 | $52K | Sell |
53,700
-465,921
| -90% | -$451K | ﹤0.01% | 3718 |
|
|
2019
Q1 | $717K | Buy |
519,621
+73,558
| +16% | +$101K | ﹤0.01% | 3398 |
|
|
2018
Q4 | $477K | Sell |
446,063
-17,130
| -4% | -$18.3K | ﹤0.01% | 3453 |
|
|
2018
Q3 | $2.85M | Buy |
463,193
+69,629
| +18% | +$428K | ﹤0.01% | 3118 |
|
|
2018
Q2 | $4.21M | Buy |
393,564
+72,539
| +23% | +$776K | ﹤0.01% | 2948 |
|
|
2018
Q1 | $3.44M | Buy |
321,025
+32,615
| +11% | +$350K | ﹤0.01% | 2954 |
|
|
2017
Q4 | $2.02M | Buy |
288,410
+19,684
| +7% | +$138K | ﹤0.01% | 3178 |
|
|
2017
Q3 | $2.35M | Buy |
268,726
+9,127
| +4% | +$79.7K | ﹤0.01% | 3132 |
|
|
2017
Q2 | $2.37M | Buy |
259,599
+129,621
| +100% | +$1.18M | ﹤0.01% | 3058 |
|
|
2017
Q1 | $1.03M | Buy |
129,978
+27,700
| +27% | +$220K | ﹤0.01% | 3256 |
|
|
2016
Q4 | $911K | Buy |
102,278
+45,671
| +81% | +$407K | ﹤0.01% | 3298 |
|
|
2016
Q3 | $980K | Buy |
+56,607
| New | +$980K | ﹤0.01% | 3199 |
|